Protein designated PEG modification method and obtained PEG modified protein
A protein and fixed-point technology, applied in the field of protein fixed-point PEG modification, can solve the problems of destroying the biological activity of proteins, uneven modified products, unstable curative effect, etc., and achieve the effects of avoiding by-products, low cost and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0128] Example 1 Preparation of Recombinant Human Growth Hormone
[0129] (1) Obtaining the recombinant vector containing human growth hormone gene:
[0130] Source of recombinant gene:
[0131] Recombinant human growth hormone gene, i.e. hGH gene: According to the human growth hormone gene published by PubMed, gene synthesis was carried out in Shanghai Bioengineering Company, that is, the gene of human growth hormone was obtained, i.e. hGH gene, which has such as SEQ ID NO: 17 Nucleotide sequence shown.
[0132]pMAL-c5x expression vector: derived from New England BioLabs Inc. Cat. NO. N8108s. The expression vector contains the MBP gene (i.e. the maltose binding protein gene) and the gene of the FXa recognition peptide IEGR. When the foreign gene is inserted, the N-terminus of the resulting fusion protein is fused with the MBP protein and the IEGR amino acid sequence after induced expression; when the recombinant protein has When the MBP protein is tagged, it is beneficial ...
Embodiment 2
[0203] Example 2 Comparison of the ability of sortase to modify different fusion human growth hormones
[0204] The source of the sortase SrtA (i.e. Sortase A): according to the construction of the Sortase A recombinant expression vector recorded in "The Inhibitory Effect of Rutin on Staphylococcus aureus Sortase A" published by Wang Yanan et al. in the Journal of Jilin Agricultural University in 2013 and It was prepared by the expression and purification method, and the obtained sorting enzyme SrtA was detected by SDS-PAGE, and the detection result was as follows: Figure 12 , where M is the molecular weight marker; lane 1 is the purified sortase; band T is the sortase SrtA; after detection, the concentration of the sortase SrtA is 5 μmol / L.
[0205] Take the primary products prepared from recombinant strain 1 to recombinant strain 7 in Example 1 (i.e. collect the bacterial cells, centrifuge the supernatant obtained after freezing and thawing), carry out PEG modification, com...
Embodiment 3
[0229] Example 3 PEG modification of growth hormone using sortase
[0230] Take the recombinant human growth hormone 1 prepared in Example 1, and add the sortase SrtA (Example Prepared by the preparation method provided in 2, the concentration is 5 μmol / L), polyethylene glycol modified dipolyglycine (PEG modifier, derived from Qiangyue Biotechnology Co., Ltd., which has the structure shown in formula (I)) , after mixing evenly, adjust the pH value to 8, and react for 18 hours at 25°C;
[0231]
[0232] Where m=4; n=220, the corresponding molecular weight of PEG is 10K.
[0233] Using the HPLC method, the resulting modified product was separated, and the eluted fraction was collected to obtain PEG-modified human growth hormone 1. The results were as follows: Figure 14 Shown, where peak 1 represents 10K PEG-modified human growth hormone 1, that is, PEG-modified human growth hormone 1; peak 2 represents unmodified recombinant human growth hormone 1; where numbers 1-21 refer...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com